483 Ajanta Pharma Feb 2017

483 Ajanta Pharma Feb 2017

Laurimer Kuilan-Torres FDA$119.00 - Available Now

FDA investigators audited the Ajanta Pharma - Aurangabad, India facility and issued inspectional observations (via FDA 483) on 07 Feb 2017.

Product details

  • Category: Human Drugs
  • Inspection end: 07 Feb 2017
  • Location: Aurangabad, India
  • FEI: 3006785788
Add To Cart